Patrick Hankey, Ph.D (@Patrick_Hankey) header
Patrick Hankey, Ph.D (@Patrick_Hankey) profile picture

VP & Founding Team, VivoSense, Inc., #Analytics, for #Wearables Data, Digital Biomarkers in #Raredisease, Oncology, Respiratory, #Pharmaceutical #ClinicalTrials

San Diego, CA
Joined May 2012
Photo by Patrick Hankey, Ph.D (@Patrick_Hankey)Photo by Patrick Hankey, Ph.D (@Patrick_Hankey)Photo by Patrick Hankey, Ph.D (@Patrick_Hankey)Photo by Patrick Hankey, Ph.D (@Patrick_Hankey)Photo by Patrick Hankey, Ph.D (@Patrick_Hankey)Photo by Patrick Hankey, Ph.D (@Patrick_Hankey)Photo by Patrick Hankey, Ph.D (@Patrick_Hankey)Photo by Patrick Hankey, Ph.D (@Patrick_Hankey)Photo by Patrick Hankey, Ph.D (@Patrick_Hankey)Photo by Patrick Hankey, Ph.D (@Patrick_Hankey)
Patrick Hankey, Ph.D retweeted
“Surviving COVID-19: The most important test may be at your fingertips” via @thehill bit.ly/2TFYiqq #pulseoximetry
2
6
Patrick Hankey, Ph.D retweeted
Pateints can stay home for their cardiac care with the Cardea SOLO Heart@Home #ECG Test Kit. #COVID19 #flattenthecurve #telehealth #telemedicine #afib gosolo.cardiacinsightinc.com…
1
3
Digital Biomarkers to Address COVID-19 Symptoms and Progression vivosense.com/blog/digital-b…
1
RSRT Partners with VivoSense to Develop Digital Biomarkers vivosense.com/blog/rsrt-part…
Exciting @VivoSense webinar on the development of #digital #biomarkers from #Wearables for use in #Pharmaceutical #clinicaltrials
Join the Webinar to gain practical know-how in bringing digital endpoints online as quickly as practically possible. Click the link to sign up. eyeforpharma.com/philadelphi…
Patrick Hankey, Ph.D retweeted
Digital Biomarker Development Process for Drug Efficacy Clinical Trial #biomarkers #vivosense ow.ly/yJ6950xT0Qe
1
2
Patrick Hankey, Ph.D retweeted
Cardiac Insight is so proud to be ranked 13th in this year's 100 Fastest Growing Private Companies List! #psbj100 #cardiacinsight #cardeasolo
The company’s revenue increased from $677,000 in 2016 to $1.8 million last year, and its sales have increased 100 percent year over year during that time, said CEO Brad Harlow bizjournals.com/seattle/news…
2
1
A recent study examining the utility & reliability of upper extremity motor activity in nonambulatory patients with #DuchenneMuscularDystrophy concluded the cumulative sum of jerks is a useful #outcomemeasure for nonambulatory #DMD patients. @NCNP_PR ow.ly/BQgq50v1ZPu
1
3
Next week at #IMPACCT, Jeremy Wyatt, ActiGraph President, will join thought leaders from @pfizer, @Sunovion & @abbvie to discuss the role of #digitalinnovation within the changing #clinicalresearch paradigm. @mHealth_Trials ow.ly/HsJw50uXumQ
2
2
Findings from a recent meta-analysis of 17 studies examining the relationship between anxiety & #sedentary behavior (SB) suggest higher levels of SB are associated with higher levels of #anxiety in child, adolescent & adult populations. @FU_Berlin @UCCS ow.ly/atH750uG6E6
2
1
The ActiGraph team is heading to San Antonio for #SLEEP2019 next week! If you're attending this event, please be sure to visit us at booth #1025! @AASMorg @ResearchSleep
1
2
Exciting to see FDA Solicit PreCert Software Developer Volunteers scq.io/XMeP45t
1
ActiGraph is pleased to announce a new partnership with data analytics specialist @vivosense, which will enhance sponsor access to secure, regulated, analyzed, and contextualized sensor data from clinical trial patients. ow.ly/ScO150umtwX
2
2
Inspired by #HeartStories in #AmericanHeartMonth with #cardiacinsight – at San Diego, CA
Looking for inspiration this #AmericanHeartMonth ? Be like CEO Brad Harlow and pick up a copy of Heart Stories by Robert G. Hauser, MD and settle in a for a great read! #HeartStories #CardeaSOLO
1
Patrick Hankey, Ph.D retweeted
Is your #ECG patch living up to its promises? Discover the advantages of going SOLO: bit.ly/2Q1PjyZ.
1
2